OR36 Bedside to Bench: Clinical and Genetic Regulation of Lipid Metabolism

Program: Abstracts - Orals, Poster Previews, and Posters
Oral Session
Cardiovascular Endocrinology-Bench to Bedside
Monday, April 4, 2016: 10:00 AM-11:30 AM
Room 160 (BCEC)
Alessandra Bitto, MD, PhD, University of Messina, Messina, Italy and To Be Determined

Nothing to Disclose: AB Disclosure Not Provided: MDH, CMA
10:00 AM
Ken Fujioka, MD1, Frank Lyons Greenway III, MD2, Michel Krempf, MD, PhD3, Carel W Le Roux, MD, PhD4, Roberto Vettor, MD5, Linda Shapiro Manning6, Søren K Lilleøre6 and Arne Astrup, MD7, (1)Division of Endocrinology, Scripps Clinic, La Jolla, CA
(2)Clinical Trials, Pennington Biomedical Research Center, Baton Rouge, LA
(3)Clinique d’endocrinologie et Nutrition, Université de Nantes, Nantes, France
(4)Diabetes Complications Research Centre, University College Dublin, Dublin, Ireland
(5)Department of Medicine, University of Padua, Padua, Italy
(6)Novo Nordisk A/S, Søborg, Denmark
(7)Department of Nutrition, Exercise and Sports, University of Copenhagen, Frederiksberg C, Denmark
10:15 AM
Mark Gabriel Athanason, Stanley Stevens, PhD and Brant R Burkhardt, Department of Cell Biology, Microbiology and Molecular Biology, University of South Florida, Tampa, FL
10:30 AM
Marcus J Lyall1, John P Thomson2, Jessy Cartier1, Raffaele Ottaviano2, Richard R Meehan2 and Amanda J Drake1, (1)BHF Centre for Cardiovascular Sciences, University of Edinburgh, Edinburgh, United Kingdom
(2)MRC Human Genetics Unit, University of Edinburgh, Edinburgh, United Kingdom
10:45 AM
Alessandra Bitto, MD, PhD1, Carmelo Gabriele Pizzino, MSc1, Natasha Irrera, MSc1, Giovanni Pallio, MSc1, Domenica Altavilla, PhD2 and Francesco Squadrito, MD1, (1)Clinical and Experimental Medicine, University of Messina, Messina, Italy
(2)University of Messina
11:00 AM
Massimiliano Ruscica1, Chiara Ricci1, Chiara Macchi2, Jingwen Liu3, Paolo Magni4, Alberto Corsini5 and Nicola Ferri6, (1)Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Milan, Italy
(2)Pharmacological and Biomolecular Sciences, Università degli Studi di Milano
(3)Veterans Affairs, Palo Alto Health Care System, CA
(4)Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Milan, Italy
(5)Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Italy
(6)Scienze del Farmaco, Università degli Studi di Padova, Italy
11:15 AM
Mabel Toribio, M.D.1, Markella V. Zanni, M.D.1, Gregory Robbins, M.D.1, Tricia H. Burdo, Ph.D.2, Min Hi Park, Ph.D.1, Meghan N Feldpausch, ANP1, Amanda Martin, A.B.1, Kathy Melbourne, PharmD3, Michael Fitzgerald, Ph.D.1 and Steven Kyle Grinspoon, M.D.1, (1)Massachusetts General Hospital, Boston, MA
(2)Boston College, Chestnut Hill, MA
(3)Gilead Sciences, Foster City, CA, USA


The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire